Niva Bupa Health files for ₹3,000-cr IPO

Niva Bupa Health Insurance, formerly Max Bupa has filed its draft red herring prospectus for a ₹3,000 crore initial public offering, of which ₹800 crore would be raised through a fresh issue and ₹2,200 crore would be an offer-for-sale by promoter and selling shareholders. Under the OFS portion, Bupa Singapore Holdings Pte would be selling…

Read More

SEBI asks MIIs to halt slab-wise charges

SEBI on Monday directed market infrastructure institutions (MIIs) to stop levying slab-wise fee structures on members, a move that could especially impact the topline of discount brokers. The existing revenue model of brokers operates similar to that of a wholesale dealer. Exchanges incentivise brokers based on turnover volume, allowing brokers to negotiate lower transaction fee…

Read More

Broker’s call: VIP Industries (Buy)

Target: ₹672 CMP: ₹483.50 The Mumbai-based luggage maker, VIP Industries Ltd (VIP), is India’s largest and world’s second-largest luggage manufacturer. Its brands cater to the mass and premium segments of the demand pyramid, with products across a wide price range. Founded in 1968, by noted industrialist Dilip Piramal, has over the years nurtured the brand…

Read More

Broker’s call: Inox Wind (Buy)

Target: ₹185 CMP: ₹143.80 We initiate coverage of Inox Wind Ltd (IWL) with a Buy recommendation and a target price of ₹185. Inox Wind is a fully integrated wind energy solutions provider. The company is engaged in the business of manufacturing and selling wind turbine generators (WTGs). It also provides erection, procurement and commissioning (EPC),…

Read More

Wockhardt Stock Price: Soars over 19% after its investigational antibiotic Zaynich successfully treats cancer patient in US

Drugmaker Wockhardt said its investigational antibiotic Zaynich (Zidebactam/Cefepime WCK 5222) was successfully used to treat a cancer patient in the United States, who had chronic bilateral thigh infection caused by an extreme-drug resistant pseudomonas. Also read: Wockhardt Q4 results: Reports net loss of ₹177 crore; antibiotic products show progress This marked the first instance in…

Read More